Sarah Null, PA | |
2560 Central Park Ave Ste 195, Flower Mound, TX 75028-1566 | |
(972) 420-1475 | |
(972) 539-8000 |
Full Name | Sarah Null |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 2560 Central Park Ave Ste 195, Flower Mound, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194031419 | NPI | - | NPPES |
PA06852 | Other | TX | LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | TEMORARY (Texas) | Secondary |
363A00000X | Physician Assistant | PA06852 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sarah Null, PA 2560 Central Park Ave Ste 195, Flower Mound, TX 75028-1566 Ph: (972) 420-1475 | Sarah Null, PA 2560 Central Park Ave Ste 195, Flower Mound, TX 75028-1566 Ph: (972) 420-1475 |
News Archive
The dermatological impact of COVID-19 is a burning topic at EADV's 2021 Spring Symposium. New research presented today highlights the effect that stringent hand hygiene during the pandemic has had on hand skin health.
Led by Dr. Peiyee Lee and Dr. Richard Gatti, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have used induced pluripotent stem cells to advance disease-in-a-dish modeling of a rare genetic disorder, ataxia telangiectasia.
A new test developed at CHU Sainte-Justine in Montreal will enable better management of patients with severe combined immunodeficiency.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 9 days ago